Clinical trials: Prognostic Factors
Hantavirus Infections, Hemorrhagic Fever With Renal Syndrome
Hantavirus Registry - HantaReg
Hantavirus disease are zoonotic infections and remain a clinical challenge with globally increasing incidence and multiple serious outbreak situations in Europe within the last years.
- Conditions
- Hantavirus Infections, Hemorrhagic Fever With Renal Syndrome, Nephropathia Epidemica, Hantavirus Cardiopulmonary Syndrome
- Trial name
- HantaReg (NCT04323904)
- Testing
- Retrospective data collection
- Where
- Germany
- Volunteers
- 200 people
- Sponsor
- University of Cologne
Lymphoma
Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.
- Trial name
- ManteauRiBVD (NCT00740415)
- Testing
- rituximab, bortezomib, dexamethasone
- Where
- France
- Volunteers
- 39 people
- Sponsor
- French Innovative Leukemia Organisation
COVID-19, Prognostic Factors
Prognosis in Pregnant With COVID-19
COVID-19 is a disease whose development, prognosis mechanism and immune status are still unknown. The aim of the study is to determine the relationship between clinical and laboratory data and the severity of the disease by…
- Conditions
- COVID-19, Prognostic Factors, Pregnancy
- Trial name
- NCT04409249
- Testing
- imaging, blood tests
- Where
- Turkey (Türkiye)
- Volunteers
- 155 people
- Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital
Esophageal Cancer
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
Esophageal cancer is one of the most common malignant tumors worldwide, with high invasiveness and lethality. Currently, the treatment for resectable locally advanced esophageal cancer mainly consists of a treatment model…
- Trial name
- NCT06889402
- Testing
- Neoadjuvant therapy with PD-L1 inhibitor
- Where
- China
- Volunteers
- 600 people
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Neonatal Abstinence Syndrome
Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome
The aim of this study is to characterize the interest of concentrations in meconium of drugs used for treatment of pregnant opioid-dependent woman as a prognostic factor of time, severity and duration of neonatal abstinence…
- Trial name
- SUBOPGEST (NCT03334981)
- Testing
- Concentrations in Meconium of Buprenorphine and Methadone
- Where
- France
- Volunteers
- 92 people
- Sponsor
- University Hospital, Caen
Idiopathic Macular Hole
Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes
The project is a randomized clinical trial with a follow up time of 12 months comparing the effects of surgical treatment of idiopathic macular holes.
- Trial name
- NCT00302328
- Testing
- macular hole operation
- Where
- Denmark
- Volunteers
- 78 people
- Sponsor
- Glostrup University Hospital, Copenhagen
Breast Cancer Female, Return to Work
ACTIVPROSEIN : Professional Activity After Breast Cancer
Breast cancer is, in term of incidence, the first cancer among women in France and worldwide. This incidence is increasing, particularly among young women during their professional activity.
- Trial name
- NCT06025604
- Where
- France
- Volunteers
- 578 people
- Sponsor
- University Hospital, Grenoble
Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators
Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors
Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies.
- Trial name
- NCT01356706
- Where
- Belgium
- Volunteers
- 274 people
- Sponsor
- University Hospital, Gasthuisberg
Crohn Disease
Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building
The project will consist of a multicentre, prospective, observational study with a total duration of 24 months. Clinical, endoscopic and ultrasound data will be collected in a dedicated database (on IG-IBD Register), which will…
- Trial name
- POCD2017 (NCT03150238)
- Testing
- observation of prognostic factors for relapse
- Where
- Italy
- Volunteers
- 220 people
- Sponsor
- Istituto Clinico Humanitas
Bile Duct Neoplasms Malignant
Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB
The main aim of this observational study is to understand the clinicopathological and prognostic information of IPNB, a rare tumor.
- Trial name
- NCT06887023
- Where
- China
- Volunteers
- 118 people
- Sponsor
- The First Hospital of Jilin University
Acute Myelogenous Leukemia
Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
The goal of Part 1 of this clinical research study is to learn about the safety of the combination of plerixafor and clofarabine when given to patients with previously untreated AML who are at least 60 years old.
- Trial name
- NCT01160354
- Testing
- Plerixafor, Clofarabine
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- M.D. Anderson Cancer Center
Adolescent Idiopathic Scoliosis
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
The purpose of this study is to identify potential markers for curve progression in adolescent idiopathic scoliosis (AIS). Despite its prevalence and impact on child health, the etiology of AIS and molecular mechanisms underlying…
- Trial name
- NCT02315729
- Where
- United States
- Volunteers
- 380 people
- Sponsor
- University of Colorado, Denver
Non Hodgkin Lymphoma (NHL)
Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL)
The Czech National Lymphoma Registry (NiHiL) was founded to monitor epidemiologic data and improve the diagnostic evaluation and quality of treatment of patients with non-Hodgkin´s lymphoma (NHL).
- Trial name
- NCT03199066
- Where
- Czechia
- Volunteers
- 20,000 people
- Sponsor
- Czech Lymphoma Study Group
Musculoskeletal Diseases, Athletic Injuries
Incidence and Prognostic Factors for Lower Extremities Injuries in Polish Youth Soccer Academy.
The aim of our study is to obtain data on the occurrence of injuries, their mechanisms and types among children and adolescents from a youth soccer club.
- Trial name
- NCT04780880
- Where
- Poland
- Sponsor
- Medical University of Gdansk
Diffuse Large B-Cell Lymphoma
An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell Lymphoma
This multicenter, observational study will evaluate the correlation between clinical and biological factors and International Prognostic Index (IPI) as prognostic factors in patients with diffuse large B-cell lymphoma receiving…
- Trial name
- NCT01724294
- Where
- Romania
- Volunteers
- 113 people
- Sponsor
- Hoffmann-La Roche
Nasal Vestibule Carcinoma, Rhinectomy
Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule
The goal of this observational study is to learn about survival and prognostic factors in patients who underwent surgical treatment for primary squamous cell carcinoma of the nasal vestibule.
- Conditions
- Nasal Vestibule Carcinoma, Rhinectomy, Nasal Vestibule, Squamous Cell Carcinoma
- Trial name
- NV-SCC (NCT05693116)
- Testing
- Rhinectomy
- Where
- 6 sites in France, Italy and 1 more
- Volunteers
- 300 people
- Sponsor
- Istituto Clinico Humanitas
COVID-19
The Prognostic Factors of COVID-19 ARDS Patients and Their Long-term Follow-up of Pulmonary Function Test
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging infectious disease with high transmissibility. Around 20-25% of infected individuals develop severe COVID-19 disease requiring hospitalization and…
- Trial name
- NCT05490914
- Where
- Taiwan
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Pancreatic Cancer
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable
This study aims to collect clinical, biological and quality of life data from patients with a borderline or resectable pancreatic cancer.
- Trial name
- Pancreas-CGE (NCT02818907)
- Testing
- Additional biological samples
- Where
- 8 sites in France
- Volunteers
- 290 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon
Myelodysplastic Syndrome
Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome
Developing a molecular genetic test that can identify prognostic factors which can predict response to treatment, and to contribute to the establishment of future therapeutic strategies base on prognostic factors by undergoing…
- Trial name
- NCT02330692
- Testing
- No intervention
- Where
- South Korea
- Volunteers
- 1,000 people
- Sponsor
- Yonsei University
Intrauterine Growth Restriction, Small-for-gestational Age
Ultrasound Evaluation of Fetal Hemodynamics and Perinatal Complications
In case of fetal weight below the 10th centile for gestational age, it is important to distinguish SGA and IUGR. SGA is defined as a fetal weight below the 10th centile.
- Trial name
- PTI'DOP (NCT03865628)
- Volunteers
- 1,200 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon